Market Capitalization (Millions $) |
12 |
Shares
Outstanding (Millions) |
21 |
Employees |
- |
Revenues (TTM) (Millions $) |
8 |
Net Income (TTM) (Millions $) |
-115 |
Cash Flow (TTM) (Millions $) |
-48 |
Capital Exp. (TTM) (Millions $) |
2 |
Vbi Vaccines Inc
VBI Vaccines Inc. is a biotechnology company that develops and commercializes novel vaccines and immunotherapies for infectious diseases. The company's focus is on developing vaccines for preventing and treating diseases such as hepatitis B, cytomegalovirus, and glioblastoma. VBI Vaccines utilizes their proprietary enveloped virus-like particle (eVLP) platform technology to design and produce vaccines that offer enhanced immune responses. Their innovative approach aims to address unmet medical needs and improve global public health by providing effective and cost-efficient vaccines.
Company Address: 160 Second Street Cambridge 2142 MA
Company Phone Number: 830-3031 Stock Exchange / Ticker: NASDAQ VBIV
|